Inhibition of cGMP-specific phosphodiesterase type 5 reduces sodium excretion and arterial blood pressure in patients with NaCl retention and ascites. (Q45197565)
Jump to navigation
Jump to search
scientific article published on 21 December 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Inhibition of cGMP-specific phosphodiesterase type 5 reduces sodium excretion and arterial blood pressure in patients with NaCl retention and ascites. |
scientific article published on 21 December 2004 |
Statements
Inhibition of cGMP-specific phosphodiesterase type 5 reduces sodium excretion and arterial blood pressure in patients with NaCl retention and ascites (English)
Helle C Thiesson
Boye L Jensen
Steen Walter
Peter D Ottosen
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference